NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
NASDAQ TRADE HALTREASON NOT AVAILABLE AT 04:00 AM
Recent news on Scribe Therapeutics
See all newsBrief: Scribe Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights
Scribe Therapeutics surges in New York debut after upsized $128.7 million IPO
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor
NASDAQ RESUMED AT 11:50 AM